Researchers randomly assigned 72 chronic cocaine users to receive either an antidepressant, lithium, or a placebo. 48 of the 72 users relapsed. Of those who received the antidepressant, 10 of 24 relapsed, giving a 42% probability of relapse among those receiving the antidepressant. The probability of relapse was higher for those receiving lithium (75%) or placebo (83%). Knowing a patient relapsed, the probability they received the antidepressant was 21%.